ロード中...
Low-density lipoprotein cholesterol lowering therapy for the secondary prevention of atherosclerotic cardiovascular disease
Atherosclerotic cardiovascular disease (ASCVD) is highly prevalent and a major contributor to morbidity and mortality worldwide. Elevated blood cholesterol is a key driver of risk for atherosclerotic events, and patients with established ASCVD comprise a specific high-risk population in which low-de...
保存先:
| 出版年: | Glob Cardiol Sci Pract |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Magdi Yacoub Heart Foundation
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7868100/ https://ncbi.nlm.nih.gov/pubmed/33598499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21542/gcsp.2020.39 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|